Established in 2020 Friday, May 27, 2022


Novel supramolecular CRISPR-Cas9 carrier enables more efficient genome editing
The PRX carrier can cross the cell membrane, avoid endosomal action, and release Cas9 RNP for entry into the nucleus. Image courtesy: Kumamoto University.



KUMAMOTO.- CRISPR-Cas9 is considered a revolutionary gene editing tool, but its applications are limited by a lack of methods by which it can be safely and efficiently delivered into cells. Recently, a research team from Kumamoto University, Japan, have constructed a highly flexible CRISPR-Cas9 carrier using aminated polyrotaxane (PRX) that can not only bind with the unusual structure of Cas9 and carry it into cells, but can also protect it from intracellular degradation by endosomes.

Clustered regularly interspaced short palindromic repeats (CRISPR) and their accompanying protein, CRISPR-associated protein 9 (Cas9), made international headlines a few years ago as a game-changing genome editing system. Consisting of Cas9 and strand of genetic material known as a single-guide RNA (sgRNA), the system can target specific regions of DNA and function as "molecular scissors" to make precise edits. The direct delivery of Cas9–sgRNA complexes, i.e. Cas9 ribonucleoproteins (RNPs), into the nucleus of the cell is considered the safest and most efficient way to achieve genome editing. However, the Cas9 RNP has poor cellular permeability, and thus requires a carrier molecule to transport it past the first hurdle of the cell membrane before it can get to the cell nucleus. These carriers need to bind with Cas9 RNP, carry it into the cell, prevent its degradation by intracellular organelles called "endosomes," and finally release it without causing any changes to its structure.

In a recent paper published in the June 2022, Volume 27 of Applied Materials Today, a research team from Kumamoto University has developed a transformable polyrotaxane (PRX) carrier that can facilitate genome editing using Cas9RNP with high efficiency and usability. "While there have been some PRX-based drug carriers for nucleic acids and proteins reported before, this is the first report on PRX-based Cas9 RNP carrier. Moreover, our findings describe how to precisely control intracellular dynamics across multiple steps. This will prove invaluable for future research in this direction," says Professor Keiichi Motoyama, a corresponding author of the paper.




For their novel carrier, the research team focused on PRX with amine groups, i.e. amino-PRX, and went through multiple rounds of development and optimization before achieving their final product. For example, the first generation (1G) of their carrier molecules, exploited the autonomous transforming properties of amino-PRX to efficiently complex it with Cas9 RNP and enable its delivery past the cell membrane. The second generation (2G) worked towards endosome-escape. This was achieved via the transformation of the amino-groups in amino-PRX into highly cationic (positively charged) particles within the endosome, which resulted in the rupturing of the endosome and the escape of Cas9 RNP–amino-PRX.

The next few generations addressed problems relating to the release of Cas9 once the complex had escaped the endosome. Finally, they developed the fifth generation (5G) multi-step transformable amino-PRX carrier that could precisely and efficiently deliver Cas9 RNP into the cell nucleus. The research team further performed in vitro and in vivo experiments to confirm the cytotoxicity of the system, as well as its genome editing efficiency.

"Our delivery system has a low cytotoxicity and its genome editing activity is equal to the current most efficient system on the market," reveals Associate Professor Taishi Higashi of Kumamoto University, who is the other corresponding author of the study. "Moreover, our multiple attempts at optimizing the delivery system across generations offers important information on the types and positions of various biodegradable groups and amino groups that can be used in such a system to further customize and adapt their properties."

The autonomous action, multi-step transformable properties, and low cytotoxicity of the 5G amino-PRX carrier make it an enormously promising candidate for the safe and efficient delivery of Cas9 RNP. These findings could furthermore be applied for the delivery of a wide range of molecules, such as enzymes, antibodies, and small interfering RNA (siRNA), thereby making this novel carrier a significant achievement in the field of drug and vaccine development.







Today's News

May 14, 2022

Discovered: 150-year-old platypus and echidna specimens that proved some mammals lay eggs

Researchers develop wireless implantable vascular monitoring system

One particle on two paths: Quantum physics is right

CUHK palaeontologist investigates the diet of prehistoric birds to reconstruct past and present ecosystems

Quantum systems and the flight of the bee

Novel supramolecular CRISPR-Cas9 carrier enables more efficient genome editing

The origin of life: A paradigm shift

3D-printing robot enables sustainable construction

Light-emitting electrochemical cells for recyclable lighting

Jellyfish's stinging cells hold clues to the emergence of new cell types

From cavefish to humans: Evolution of metabolism in cavefish may provide insight into treatments for a host of diseases

Ancient microorganisms found in halite may have implications for search for life

Researchers find a trigger for cell suicide; could lead to new skin infection therapies

Multi-tissue cell atlases lead to leap of understanding of immunity and disease

Optical cavities could provide new technological possibilities

AI traffic light system could make traffic jams a distant memory

New tech can double spectral bandwidth in some 5G systems

What we're still learning about how trees grow



 


Editor & Publisher: Jose Villarreal
Art Director: Juan José Sepúlveda Ramírez



Tell a Friend
Dear User, please complete the form below in order to recommend the ResearchNews newsletter to someone you know.
Please complete all fields marked *.
Sending Mail
Sending Successful